Search research articles
Contact Us
Filters
Showing results (181-190 of 252) with videos related to
Page
of 26
Sort By:
British Journal of Haematology
|
March 18, 2014
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
Ryan D Gentzler, Andrew M Evens, Alfred W Rademaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma
Jane N Winter, David J Inwards, Stewart Spies, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 5, 2016
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex
Zheng Zhou, Alfred W Rademaker, Leo I Gordon, et al.
Vaccine
|
June 16, 2009
Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia
D Pathirana, P Hillemanns, K-U Petry, et al.
Blood
|
February 2, 2006
Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study
Jane N Winter, Edie A Weller, Sandra J Horning, et al.
Blood Advances
|
July 24, 2025
Nivolumab in Combination with R-CHOP for Treatment-Naïve Diffuse Large B-Cell Lymphoma: An Evaluation of Safety and Efficacy
Oluwatobi Odetola, Shuo Ma, Jane N Winter, et al.
Blood Advances
|
September 9, 2022
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma
Pamela B Allen, Xinyan Lu, Qing Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study
Anjali Advani, Bertrand Coiffier, Myron S Czuczman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2020
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408
Andrew M Evens, Fangxin Hong, Thomas M Habermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells
J N Winter, H M Lazarus, A Rademaker, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 252) with videos related to
Sort By:
Page
of 26
British Journal of Haematology
|
March 18, 2014
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
Ryan D Gentzler, Andrew M Evens, Alfred W Rademaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma
Jane N Winter, David J Inwards, Stewart Spies, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 5, 2016
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex
Zheng Zhou, Alfred W Rademaker, Leo I Gordon, et al.
Vaccine
|
June 16, 2009
Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia
D Pathirana, P Hillemanns, K-U Petry, et al.
Blood
|
February 2, 2006
Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study
Jane N Winter, Edie A Weller, Sandra J Horning, et al.
Blood Advances
|
July 24, 2025
Nivolumab in Combination with R-CHOP for Treatment-Naïve Diffuse Large B-Cell Lymphoma: An Evaluation of Safety and Efficacy
Oluwatobi Odetola, Shuo Ma, Jane N Winter, et al.
Blood Advances
|
September 9, 2022
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma
Pamela B Allen, Xinyan Lu, Qing Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study
Anjali Advani, Bertrand Coiffier, Myron S Czuczman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2020
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408
Andrew M Evens, Fangxin Hong, Thomas M Habermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells
J N Winter, H M Lazarus, A Rademaker, et al.
Page
of 26